|
|
|
|
| LEADER |
00000cam a2200000 i 4500 |
| 001 |
SCIDIR_ocn962411860 |
| 003 |
OCoLC |
| 005 |
20231120112151.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
161109s2017 enk o 000 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e rda
|e pn
|c IDEBK
|d N$T
|d YDX
|d EBLCP
|d NLE
|d OCLCO
|d OPELS
|d N$T
|d OCLCF
|d OCLCQ
|d OTZ
|d IDEBK
|d OCLCQ
|d U3W
|d MERUC
|d D6H
|d YDX
|d OCLCO
|d MERER
|d OCLCQ
|d NTE
|d UWO
|d UHL
|d OCLCQ
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 962303012
|a 962326192
|a 965136732
|a 1162520562
|
| 020 |
|
|
|a 9780128028032
|q (electronic book)
|
| 020 |
|
|
|a 0128028033
|q (electronic book)
|
| 020 |
|
|
|z 0128027924
|
| 020 |
|
|
|z 9780128027929
|
| 035 |
|
|
|a (OCoLC)962411860
|z (OCoLC)962303012
|z (OCoLC)962326192
|z (OCoLC)965136732
|z (OCoLC)1162520562
|
| 050 |
|
4 |
|a QP88.2
|b .M38 2017
|
| 072 |
|
7 |
|a MED
|x 085000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 617.471
|2 23
|
| 245 |
0 |
0 |
|a Materials and devices for bone disorders /
|c edited by Susmita Bose, Amit Bandyopadhyay.
|
| 264 |
|
1 |
|a London, United Kingdom ;
|a San Diego, CA :
|b Academic Press,
|c [2017]
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Front Cover; Materials and Devices for Bone Disorders; Copyright Page; Contents; List of Contributors; Biography; Preface; 1 Introduction to Biomaterials and Devices for Bone Disorders; 1.1 Introduction; 1.2 Metallic Biomaterials; 1.3 Ceramic Biomaterials; 1.4 Polymeric Biomaterials; 1.5 Composite Biomaterials; 1.6 Additive Manufacturing (AM) of Biomaterials; 1.7 Biomaterials in Orthopedic Implants Devices; 1.7.1 Joint replacements; 1.7.2 Implants used in osteosynthesis for stabilization and fracture repair; 1.7.3 Spine implants; 1.7.4 Nonconventional implants for bone tumor.
|
| 505 |
8 |
|
|a 1.7.5 Multifunctional devices1.8 Summary and Future Directions; Acknowledgments; References; 2 Bone Biology and Effects of Pharmaceutical Intervention on Bone Quality; 2.1 Bone Biology; 2.1.1 Bone functions; 2.1.2 Composition; 2.1.3 Architecture; 2.1.4 Bone cells; 2.1.4.1 Osteoclasts; 2.1.4.2 Osteoblast lineage; 2.1.4.2.1 The Wnt-signaling system; 2.1.4.3 Preosteoblasts; 2.1.4.4 Reversal cells; 2.1.4.5 Mature osteoblasts; 2.1.4.6 Lining cells; 2.1.4.7 Osteocytes; 2.1.5 Bone remodeling; 2.1.5.1 The basic multicellular unit; 2.1.5.2 Sequence of bone remodeling; 2.1.5.2.1 Origination.
|
| 505 |
8 |
|
|a 2.1.5.2.2 Activation2.1.5.2.3 Resorption; 2.1.5.2.4 Reversal; 2.1.5.2.5 Formation; 2.1.5.2.6 Mineralization; 2.1.5.2.7 Reestablishing osteocyte network; 2.1.5.2.8 Quiescence; 2.1.6 Fracture repair; 2.1.6.1 Stress fractures; 2.1.6.2 Complete fractures; 2.1.7 Aspects of bone strength; 2.1.7.1 Bone shape; 2.1.7.2 Bone volume; 2.1.7.3 Mineralization density; 2.1.7.4 Microarchitecture; 2.1.7.5 Collagen structure; 2.1.7.6 Ability to repair damage; 2.1.7.7 Crystal characteristics; 2.1.7.8 Bone marrow; 2.1.7.9 Overall bone strength; 2.2 Pharmaceutical Intervention.
|
| 505 |
8 |
|
|a 2.2.1 Bone loss with aging or disease2.2.2 Actions of systemic hormones and local cytokines; 2.2.2.1 Estrogen; 2.2.2.2 Glucocorticosteroids; 2.2.2.3 Thyroid; 2.2.2.4 Parathyroid; 2.2.2.5 Calcitonin; 2.2.2.6 1,25 (OH)2-Cholecalciferol (1,25D); 2.2.2.7 Insulin and insulin-like growth factor; 2.2.2.8 Serotonin; 2.2.2.9 Local cytokines; 2.2.3 Calcium supplementation; 2.2.4 Bone formation with osteoporosis medications; 2.2.5 Raloxifene; 2.2.6 Bisphosphonates; 2.2.6.1 Short-term effects; 2.2.6.2 Long-term effects; 2.2.6.3 Fracture healing; 2.2.7 Denosumab; 2.2.8 Teriparatide; 2.2.9 Strontium.
|
| 505 |
8 |
|
|a 2.2.10 Emerging therapies2.2.10.1 Cathepsin K inhibitors; 2.2.10.2 Romosozumab; 2.2.11 Other medications or substances that affect bone strength; 2.2.11.1 Anticonvulsants; 2.2.11.2 Selective serotonin reuptake inhibitors; 2.2.11.3 Carbonic anhydrase inhibitors; 2.2.11.4 Thiazide diuretics; 2.2.11.5 Rosiglitazone; 2.2.11.6 Bortezomib; 2.2.11.7 Lithium; 2.2.11.8 Elements toxic to the bone; 2.2.11.9 Fluoride; 2.3 Summary; References; 3 Bone Disorders; 3.1 Introduction; 3.2 Metabolic Diseases; 3.2.1 Osteoporosis; 3.2.2 Paget's disease; 3.3 Degenerative Disc Disease; 3.4 Osteoarthritis.
|
| 588 |
0 |
|
|a Online resource; title from digital title page (viewed on October 26, 2018).
|
| 650 |
|
0 |
|a Bones
|x Mechanical properties.
|
| 650 |
|
0 |
|a Bones
|x Diseases
|x Treatment.
|
| 650 |
|
6 |
|a Os
|x Propri�et�es m�ecaniques.
|0 (CaQQLa)201-0131278
|
| 650 |
|
6 |
|a Os
|0 (CaQQLa)201-0000241
|x Maladies
|0 (CaQQLa)201-0000241
|x Traitement.
|0 (CaQQLa)201-0377521
|
| 650 |
|
7 |
|a MEDICAL
|x Surgery
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a Bones
|x Diseases
|x Treatment
|2 fast
|0 (OCoLC)fst00836014
|
| 650 |
|
7 |
|a Bones
|x Mechanical properties
|2 fast
|0 (OCoLC)fst00836023
|
| 700 |
1 |
|
|a Bose, Susmita,
|e editor.
|
| 700 |
1 |
|
|a Bandyopadhyay, Amit,
|d 1967-
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Materials and devices for bone disorders.
|d London, United Kingdom ; San Diego, CA : Academic Press, [2017]
|z 0128027924
|z 9780128027929
|w (OCoLC)954535271
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128027929
|z Texto completo
|
